Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension.

  title={Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension.},
  author={C Huang and Wan-leong Chan and Yu-Chun Chen and Tzeng-Ji Chen and S. -R. Lin and Jaw-Wen Chen and H. -S. Leu},
  journal={The American journal of cardiology},
  volume={107 7},
Recently, concerns have been raised that angiotensin II receptor blockers (ARBs) may be associated with an increased risk for cancer development. However, the relation between ARBs and cancer is still unclear. Therefore, a nationwide population-based study was conducted to investigate the possible influence of ARBs on the occurrence of new cancers in patients with hypertension by using the Taiwan National Health Insurance database. A total of 109,002 patients with newly diagnosed hypertension… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 33 extracted citations

Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2011
View 12 Excerpts
Highly Influenced

Renin–angiotensin system blockade for the risk of cancer and death

Journal of the renin-angiotensin-aldosterone system : JRAAS • 2016

Strategies and Challenges in Clinical Trials Targeting Human Aging

The journals of gerontology. Series A, Biological sciences and medical sciences • 2016
View 1 Excerpt

Angiotensin receptor blockers (ARBs) reduce the risk of lung cancer: a systematic review and meta-analysis.

International journal of clinical and experimental medicine • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…